Buy & Sell DENTSPLY SIRONA Inc (XRAY) – DENTSPLY SIRONA Inc Price Today
Aura AI Summary
Key Stats
- $2.04BMarket Cap
- HealthSector
- -33.65%3M Drawdown
- $4.19BEnterprise Value
- 5.04%Dividend Yield
- 65 daysTypical Hold Time
DENTSPLY SIRONA Inc (XRAY) is currently valued at a market capitalization of $2.04B, with an enterprise value of $4.19B. Over the past 52 weeks, DENTSPLY SIRONA Inc has traded between a low of $9.74 and a high of $16.85, highlighting its annual price range. Over the past three months, DENTSPLY SIRONA Inc has recorded a drawdown of -33.65%, reflecting recent price volatility. DENTSPLY SIRONA Inc offers a dividend yield of 5.04%, with the most recent dividend of $0.16 paid on 26 Dec 25. On average, investors hold DENTSPLY SIRONA Inc for approximately 65 days, indicating typical investor behavior on the platform.
About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Most Recent News
Torque Asset Management buys $4M of Planet Fitness stock amid 54% drop in 2026
Torque Asset Management has purchased $4 million worth of Planet Fitness shares despite the stock falling 54% so far in 2026. This move suggests confidence in the company's long-term prospects despite recent market challenges. Investors may watch for...

Enhanced Games debuts in Las Vegas with boosted athletes and a TikTok-friendly sports format
Enhanced Games will hold its first competition in Las Vegas featuring 50 enhanced athletes, including Olympic and world champions, competing in a new sports format designed for digital and social media viewing. The event combines track, pool, and wei...

Phibro Animal Health CEO sold 21,120 shares worth $1.2 million
Phibro Animal Health's CEO recently sold 21,120 shares of the company, generating proceeds of approximately $1.2 million. This insider sale might indicate the CEO's personal financial planning or a strategic move, but it could also raise questions am...
